<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: SEL1L gene product is implicated in the endoplasmic reticulum (ER)-associated protein degradation and Unfolded Protein Response pathways </plain></SENT>
<SENT sid="1" pm="."><plain>This gene and associated miRNAs have been indicated as predictive and prognostic markers of <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>AIM: Explore the role of SEL1L in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) progression </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: SEL1L expression was analysed immunohistochemically in 153 <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 71 CRCs from African American and North Italian patients </plain></SENT>
<SENT sid="4" pm="."><plain>The distribution of stained cells was determined by computing median and inter quartile range </plain></SENT>
<SENT sid="5" pm="."><plain>The receiver operating characteristics plot was used as discriminate power of SEL1L expression, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> diagnosis and the effects on patient survival </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: SEL1L was low in <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa and confined to few scattered cells at the base crypt of the villi and in the foveolar glandular compartment </plain></SENT>
<SENT sid="7" pm="."><plain>The highest levels were in Paneth cells within the lysosomes </plain></SENT>
<SENT sid="8" pm="."><plain>The enterocytic progenitor cells and mature enterocytes showed less cytoplasmic staining </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, SEL1L expression significantly correlated with the progression from <z:mpath ids='MPATH_270'>adenoma</z:mpath> to <z:mp ids='MP_0002038'>carcinoma</z:mp> (P = 0.0001) being stronger in well-to-moderately differentiated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>No correlation was found with other clinicopathological characteristics or ethnicity </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: SEL1L expression is a potential <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissue biomarker since its expression is significantly higher in <z:mpath ids='MPATH_270'>adenoma</z:mpath> cells with respect to <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="12" pm="."><plain>The levels of expression decrease sensibly in undifferentiated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Interestingly, Paneth cells contain high levels of SEL1L protein that could indicate pre-neoplastic mucosa undergoing <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>Since SEL1L's major function lies within ER stress and active ERAD response, it may identify <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> with differentiated secretory phenotype and <z:hpo ids='HP_0011009'>acute</z:hpo> cellular stress </plain></SENT>
</text></document>